Advertisement

Topics

SELEXIS Company Profile

02:52 EST 16th December 2018 | BioPortfolio

July 2005Opening of the new R&D facility in Plan-les-OuatesSelexis is a private, Swiss-based biotechnology company leading the development of innovative solutions using proprietary technologies and expression systems for the rapid production of proteins for R&D and therapeutic applications. Industry experts are looking for novel and innovative solutions to increase the yields of recombinant proteins and to rapidly advance products into production for clinical phases.Referred to as MARtech, Matrix Attachment Region technologies provide powerful and flexible integrated solutions for cellular protein production. Selexis’ MARtech offers a number of significant advantages over traditional approaches including:- Acceleration of drug discovery by reducing the development time up to 8 months. Knowing that a delay of a single day can cost a pharmaceutical company between US$1 million and US$13 million in lost sales, this is a huge benefit.

Location

655, Montgomery St. STE 540
San Francisco
California
94111
United States of America

Contact

Phone: 1 415 273 51 41
Fax: 1 415 837 32 04
Email: info@selexis.com


News Articles [13 Associated News Articles listed on BioPortfolio]

Selexis and Symphogen expand partnership to progress two mAbs

Selexis and Symphogen have announced that the latter has submitted INDs for clinical programmes to progress two mAbs using Selexisâ platform.

Selexis, Hoba Therapeutics in Development Pact

Selexis will use its SUREtechnology Platform to develop a stable, high-performance research cell bank

Selexis, Symphogen Expand Partnership

Under the terms of an earlier license agreement, Symphogen has opened two INDs for clinical programs utilizing Selexis’ SGE

Selexis and Hoba collaborate on neuropathy pain treatment

Selexis and Hoba Therapeutics have entered an agreement to advance Hobaâs clinical candidate for the treatment of peripheral neuropathic pain.

Symphogen A/S and Selexis Expand Relationship as Symphogen Advances its Monoclonal Antibody (mAb) Mixture Pipeline

Selexis SA today announced that under the terms of an earlier commercial license agreement, Symphogen A/S has opened two investigational new drug applications (INDs) for ...

Meet with Selexis Scientific and Business Leaders at Several Upcoming Industry Conferences and Events

Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today that several of its scientific and business...

Selexis, Berkeley Lights Form Cell Line Collaboration

Effort designed to speed drug candidates into the clinic

Selexis SA and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic

Selexis SUREtechnology Platform™ Successfully Expresses Hoba’s HB-086 in CHO Cells Selexis SA and Hoba Therapeutics announced today that they have entered in...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [10 Associated Companies listed on BioPortfolio]

Selexis SA

Selexis is a privately held Swiss biotechnology company dedicated to the development of innovative technologies and expert services that enable significant improvements in the time, effort, and costs ...

Selexis SA and Berkeley Lights, Inc.

Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly d...

Selexis SA and Hoba Therapeutics

Selexis SA is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly d...

Selexis SA and TeneoBio, Inc.

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

Selexis SA and Turgut Pharmaceuticals

Selexis SA is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology a...

More Information about "SELEXIS" on BioPortfolio

We have published hundreds of SELEXIS news stories on BioPortfolio along with dozens of SELEXIS Clinical Trials and PubMed Articles about SELEXIS for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SELEXIS Companies in our database. You can also find out about relevant SELEXIS Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record